Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting in Chicago

ARLINGTON, Va., August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced today the top-rated studies to be highlighted in the press program for the 2019 ASTRO Annual Meeting. Researchers will present their findings in three news briefings being held September 15 through 17 in room W474B of McCormick Place in Chicago and via live webcast. Reporters can register to cover the meeting and news briefings at www.astro.org/ASTRO19press.

The briefing schedule is as follows:

Sunday, September 15, 1:30 – 2:30 p.m. Central

• “Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial,” presented by Dr. Daniel Spratt, University of Michigan Rogel Cancer Center (Abstract LBA-1)
• “Primary Outcomes of a Phase II Randomized Trial of Observation versus Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE),” presented by Dr. Ryan Phillips, Johns Hopkins Kimmel Cancer Center (Abstract LBA-3)
• “Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial,” presented by Dr. Julia White, The Ohio State University Comprehensive Cancer Center (Abstract 5)
• “Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT),” presented by Dr. Clifford Robinson, Washington University School of Medicine in St. Louis (Abstract LBA-4)

Monday, September 16, 10:30 – 11:30 a.m. Central

• “Final Results of a Phase II Prospective Trial Evaluating the Combination of Stereotactic Body Radiotherapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC),” presented by Dr. Allison Campbell, Yale Cancer Center (Abstract 74)
• “Patterns of Disease Progression with Durvalumab in Stage III NSCLC (PACIFIC),” presented by Dr. Andreas Rimner, Memorial Sloan Kettering Cancer Center (Abstract LBA-6)
• “Applying a Machine Learning Approach to Predict Acute Radiation Toxicities for Head and Neck Cancer Patients,” presented by Dr. Jay P. Reddy, The University of Texas MD Anderson Cancer Center (Abstract 141)
• “The Impact of the Closure of Women’s Health Clinics on Cervical Cancer in the United States,” presented by Dr. Amar Srivastava, Washington University School of Medicine in St. Louis (Abstract 202)

Tuesday, September 17, 1:30 – 2:15 p.m. Central

• Researchers will present updates of practice-changing trials in radiation oncology, and ASTRO leadership will highlight breakthroughs and key findings from the year’s largest cancer research meetings

Credentialed journalists from accredited news organizations are invited to attend and report on the meeting, or to cover it remotely. Information on press registration and housing is available in the online press kit. ASTRO will host an on-site press office in McCormick Place room W474A during business hours, and interview rooms are available to reserve on a first-come, first-serve basis.

General information about the meeting is available at the ASTRO Annual Meeting webpage. For questions about the press program, press registration and interview rooms, contact ASTRO’s media relations team at [email protected] or 703-286-1600.

ABOUT THE ASTRO ANNUAL MEETING

The 2019 ASTRO Annual Meeting is expected to attract more than 10,000 oncologists, clinicians, researchers and other health care professionals from across the globe. Throughout the four-day meeting, researchers will present peer-reviewed abstracts on advances in clinical care for cancer patients, while panels and interactive case discussions featuring leading experts will underscore the meeting’s theme, “Innovate, Collaborate: Transform.”

ABOUT ASTRO

The American Society for Radiation Oncology (ASTRO) is the world’s largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. The Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the nonprofit foundation Radiation Oncology Institute. To learn more about ASTRO, visit astro.org or RTanswers.org, sign up to receive our news and follow us on our blog, Facebook and Twitter.

scraped from https://www.newswise.com/articles/radiation-oncology-research-and-clinical-trial-results-to-be-featured-at-astro-s-annual-meeting-in-chicago